Skip to main content
Loading

Aptah Bio

October 17, 2023
Franciscan D
Oncology
Aptah's molecule is the first and only compound that assures accurate RNA processing of multiple proteins. It works as a template for overall RNA quality control, altering the fate of diseased cells with no harmful effect on the healthy ones. The great majority of diseases, including most age-related diseases, are NOT related to genetic mutations but rather to how the DNA is processed to produce all our proteins, the so-called RNA processing. At Aptah Bio, we developed a novel molecule targeting a fundamental element in RNA processing that regulates the production of all our proteins. If this specific element fails to work properly, it leads to the production of multiple toxic proteins, a common event in age-related diseases, such as dementia and many kinds of cancer.
Speakers
Rafael Bottos, CEO - Aptah Bio

State

California

Country

United States

Website

https://www.aptah-bio.com/

CEO/Top Company Official

Rafael Bottos

Lead Product in Development

Age-related diseases: Glioblastoma Multiforme - GBM-IDH-WT. Age-Related Macular Degeneration - Dry. Metabolic Dysfunction. Neurodegenerative Diseases (FTD, ALS, AD).

Development Phase of Primary Product

Pre-Clinical

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS